Substance / Medication

Botulinum toxoid type B

Overview

Active Ingredient
botulinum toxin type B
RxNorm CUI
2167673

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Treatment strategies for clozapine-induced sialorrhea in France: A systematic review.
Rousseau-Voisin Amélie, Javelot Hervé, Lach Franck et al. · Encephale · 2025
PMID: 40328543Meta-Analysis
Localizing value of ictal hypersalivation/sialorrhea and ictal spitting: A systematic review.
Dimova Petia S, Milenova Yoana, Stoyanova Denitza et al. · Epileptic Disord · 2025
PMID: 40332457Meta-Analysis
Onabotulinum Toxin A (BoNT-A) for Drooling in Children: A Systematic Review and Meta-Analysis.
Oad Haresh, Maltezeanu Alix, da Silva Sabrina D et al. · Laryngoscope · 2024
PMID: 38294288Meta-Analysis
Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis.
Yellepeddi Venkata K, Race Jonathan A, McFarland Mary M et al. · Int J Clin Pharmacol Ther · 2024
PMID: 38577753Meta-Analysis
Management of sialorrhea in children: a systematic review.
Vasconcelos Manuela Leitão de, Cunha Divany Guedes Pereira da, Alves Giorvan Ânderson Dos Santos et al. · Rev Assoc Med Bras (1992) · 2024
PMID: 38655996Meta-AnalysisFull text (PMC)
A systematic review of the perspectives of botulinum toxin use on the quality of life of neurological patients with drooling.
Silva Michelle Almeida, da Silveira Márcia Maria Fonseca, Pedrosa Bruna Rafaele Vieira et al. · Clin Oral Investig · 2024
PMID: 38758415Meta-Analysis
Outcome of kinesio taping in drooling children: A systematic review.
Saniasiaya Jeyasakthy, van der Meer Graeme, Toll Ed C · Int J Pediatr Otorhinolaryngol · 2024
PMID: 39121685Meta-Analysis
Effects of elastic therapeutic taping on reducing drooling in children with neurological disorders: a systematic review of randomized controlled trials.
Lam Krystal Tsz Ting, Hung Alex Tsz Wai, Lau Kendy et al. · J Neurodev Disord · 2024
PMID: 39701960Meta-AnalysisFull text (PMC)
Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson's disease: a systematic review and network meta-analysis.
Santos Junior Luiz Carlos, Santos José Ronaldo, Reis Alessandra et al. · Clin Oral Investig · 2023
PMID: 37036514Meta-Analysis
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials.
Fornaro Michele, Caiazza Claudio, Solini Niccolò et al. · Mol Psychiatry · 2023
PMID: 37821573Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Botulinum toxoid type B (substance)
SNOMED CT
409571000
UMLS CUI
C0006051
RxNorm CUI
2167673

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.